In-depth studies of the expression of CPEB1 and COLEC12 in fibroblasts and their roles in immune microenvironment interactions, particularly the complicated mechanisms connecting fibroblasts with immune cells, might provide novel strategies for BC immunotherapies in patients with diabetes. The gene discussed is CPEB1; the disease is diabetes mellitus.